PrimeRFP SCOUT · Federal Contract Recompete Brief

75F40124C00130THIS requirement IS for the generation — Massachusetts Institute of Technology

Massachusetts Institute of Technology holds $41.3M across 94 federal awards, concentrated at National Aeronautics and Space Administration (NASA). This PIID sits alongside 5 related awards in the incumbent pipeline. The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: NONE. PoP ended Jun 28, 2026 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

Fda Office Of Acq Grant Svcs
Awarding office
Massachusetts Institute of Technology
Recipient
Jun 28, 2026
PoP end
$1.8M
Obligated
$6M
Potential
541714
NAICS
AJ11
PSC
NONE
Set-aside
1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Massachusetts Institute of Technology — $90

Contract facts

NONE
Contract number75F40124C00130
AgencyFda Office Of Acq Grant Svcs
Awarding officeFda Office Of Acq Grant Svcs
Awarding agencyDepartment of Health and Human Services (HHS)
Funding agencyDepartment of Health and Human Services (HHS)
IncumbentMassachusetts Institute of Technology
CAGE80230
UEIE2NYLCDML6V1
NAICS541714

No full NAICS 541714 intel page yet. Browse NAICS intelligence

PSCAJ11
Place of performanceCAMBRIDGE MA
Pricing typeFirm Fixed Price
Extent competedCompeted Under SAP
Related solicitationFDABAA-24-00123
PoP startSep 18, 2024
PoP end (current)Jun 28, 2026
PoP end (w/ options)Sep 29, 2027
Obligated$1.8M
Current value$1.8M
Potential value$6M

THIS REQUIREMENT IS FOR THE GENERATION OF A BAA TO ADDRESS THE ONGOING GROWTH IN CONTINUOUS MANUFACTURING WITHIN CELL LINES. THIS REQUIREMENT IS BEING FUNDED THROUGH THE PRESIDENT'S TARGET INCREASE FOR FOCUS ON ADVANCE MANUFACTURING AND WILL FOC is a federal NONE award for Fda Office Of Acq Grant Svcs held by Massachusetts Institute of Technology. Estimated value $6M ($1.8M obligated). Current period of performance ends Jun 28, 2026 (potential Sep 29, 2027). Last award drew 1 bidder. Place of performance: CAMBRIDGE MA. Related solicitation FDABAA-24-00123.

THIS REQUIREMENT IS FOR THE GENERATION OF A BAA TO ADDRESS THE ONGOING GROWTH IN CONTINUOUS MANUFACTURING WITHIN CELL LINES. THIS REQUIREMENT IS BEING FUNDED THROUGH THE PRESIDENT'S TARGET INCREASE FOR FOCUS ON ADVANCE MANUFACTURING AND WILL FOC

Recompete timing

Public
Past PoP end (54 days ago)

Current PoP ended Jun 28, 2026 (54 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Incumbent footprint

Public record

Massachusetts Institute of Technology$41.3M obligated across 94 awards (firm-wide, all agencies) · lead buyer National Aeronautics and Space Administration (NASA).

% of firm-wide obligated ($41.3M) · all agencies
National Aeronautics and Space Administration (NASA)$20.6M · 50%Department of Defense (DOD)$14.0M · 34%Department of Health and Human Services (HHS)$6.4M · 15%Department of Transportation (DOT)$186K · 0%
Open full company profile

Related awards

Same incumbent
80GSFC25CA019
ADVANCED X-RAY IMAGING SATELLITE (AXIS) PHASE A RESEARCH
$861K
Aug 31, 2026
80NSSC24PB552
RESEARCH RELIABLE AUTONOMOUS SYSTEMS LAB AT MIT (REALM)-1-YEAR RESEARCH SUPPORT FROM DR. C…
$125K
Aug 31, 2026
HR001120C0191
OPEN PROGRAMMABLE SOURCE 5G TECHNICAL AREA 2
$5.2M
Sep 25, 2026
75F40122C00200
DEVELOPMENT OF AN INTEGRATED CONTINUE CGMP FACILITY FOR MRNA MANUFACTURING - BAA-PMQWP#364
$82.2M
Sep 28, 2026
75F40123C00200
MECHANISTIC MODELING AND PROCESS ANALYTICAL TECHNOLOGY FOR EXOSOME PRODUCTION
$3.3M
Sep 29, 2026

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract 75F40124C00130?

75F40124C00130 (THIS requirement IS for the generation) is a Fda Office Of Acq Grant Svcs award with a potential value of $6M, currently held by Massachusetts Institute of Technology. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75F40124C00130?

Fda Office Of Acq Grant Svcs awarded 75F40124C00130 to Massachusetts Institute of Technology (potential $6M).

Who is the incumbent on 75F40124C00130?

Massachusetts Institute of Technology is the incumbent with $41.3M across 94 related awards in SCOUT’s public footprint. The current period of performance ends Jun 28, 2026.

When does Massachusetts Institute of Technology’s 75F40124C00130 come up for recompete?

SCOUT tracks a period-of-performance end of Jun 28, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/75F40124C00130